Комбинированная терапия бронхиальной астмы: возможности изменения объема терапии
Комбинированная терапия бронхиальной астмы: возможности изменения объема терапии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Глобальная стратегия лечения и профилактики бронхиальной астмы (GINA). Пересмотр 2006 г. Пер. с англ. М.: Атмосфера, 2007.
2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004; 59: 469–78.
3. Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies Allergy 2010; 65: 152–7.
4. Бронхиальная астма. Клинические рекомендации. М.: Атмосфера, 2008.
5. Papiris SA, Manali ED, Kolilekas L et al. Acute severe asthma: new approaches to assessment and treatment. Drugs 2009; 69 (17): 2363–91.
6. British Guideline on the Management of Asthma, Thorax 2008; 63: Suppl 4.
7. T Haahtela, LE Tuomisto, A Pietinalho et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663–70.
8. Barnes PJ. Scientific rationale for using a single inhaler for asthma control Eur Respir J 2007; 29: 587–95.
9. Pauwels RA, Lofdahl C-G, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1412–8.
10. Miles Weinberger Respiratory infections and asthma:current treatment strategies. DDT 2004; 9 (19): 831–7.
11. Johnston SL et al. The relationship between upper respiratoryinfections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996; 154, 654–60.
12. Хаитов Р.М. Клиническая аллергология. М.: МЕДпресс-информ, 2002.
13. Nicholson PJ, Cullinan P, Taylor AJ et al. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 2005; 62 (5): 290–9.
14. Szczeklik A, Stevenson DD. Aspirin–induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111 (5): 913–21.
15. McFadden ER, Gilbert IA. Exercise-induced asthma. N Engl J Med 1994; 330: 1362.
16. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 2001; 163: 32–6.
17. Ketchell RI, Jensen MW, Lumley P et al. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. J Allergy Clin Immunol 2002; 110: 603–6.
18. Chalmers GW, Macleod KJ, Little SA et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57: 226–30.
19. Chaudhuri R, Livinston E, McMahon AD et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168: 1308–11.
20. O'Byrne PM, Bisgaard H, Godard PP et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171: 129–36.
21. Edwards SJ, Gruffydd-Jones K, Ryan DP. Systematic review and meta-analysis of budesonide/formoterol in a single inhaler. Cur Med Res Opin 2007; 23 (8): 1809–20.
22. Ferrari M, Balestreri F, Baratieri S et al. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma. Respiration. 2000; 67: 510–3.
23. Vilsvik J, Ankerst J, Palmqvist M et al. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis. Respir Med 2001; 95: 484–90.
24. Шмелев Е.И. Сочетание бронхиальной астмы и хронической обструктивной болезни легких. Сons Med 2004; 6 (10): 29–33.
25. Mcleish AC, Zvolensky MJ. Asthma and sigarette smoking: a review of the empirical literature. J Asthma 2010; 47: 345–61.
26. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728–73.
27. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004; 126: 117–4.
28. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких. Пересмотр 2007 г. Пер. с англ. М.: Атмосфера, 2008.
29. Чучалин А.Г., Уханова О.П., Шутов Ю.Е. и др. Открытое проспективное наблюдательное исследование эффективности и безопасности свободной комбинации Форадил Аэролайзер и ИГКС у больных БА. Атмосфера, 2009; 4: 26–32.
30. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246–51.
31. van Beerendonk I, Mesters I, Mudde AN et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998; 35: 273–9.
32. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005; 50: 1360–74.
33. Bronsky EA et al. Current medical research and opinion 2004; 20 (2): 131–7.
34. Chew NY, Chan HK. J Aerosol Med 2001; 14 (4): 495–501.
2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004; 59: 469–78.
3. Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies Allergy 2010; 65: 152–7.
4. Бронхиальная астма. Клинические рекомендации. М.: Атмосфера, 2008.
5. Papiris SA, Manali ED, Kolilekas L et al. Acute severe asthma: new approaches to assessment and treatment. Drugs 2009; 69 (17): 2363–91.
6. British Guideline on the Management of Asthma, Thorax 2008; 63: Suppl 4.
7. T Haahtela, LE Tuomisto, A Pietinalho et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663–70.
8. Barnes PJ. Scientific rationale for using a single inhaler for asthma control Eur Respir J 2007; 29: 587–95.
9. Pauwels RA, Lofdahl C-G, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1412–8.
10. Miles Weinberger Respiratory infections and asthma:current treatment strategies. DDT 2004; 9 (19): 831–7.
11. Johnston SL et al. The relationship between upper respiratoryinfections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996; 154, 654–60.
12. Хаитов Р.М. Клиническая аллергология. М.: МЕДпресс-информ, 2002.
13. Nicholson PJ, Cullinan P, Taylor AJ et al. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 2005; 62 (5): 290–9.
14. Szczeklik A, Stevenson DD. Aspirin–induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111 (5): 913–21.
15. McFadden ER, Gilbert IA. Exercise-induced asthma. N Engl J Med 1994; 330: 1362.
16. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 2001; 163: 32–6.
17. Ketchell RI, Jensen MW, Lumley P et al. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. J Allergy Clin Immunol 2002; 110: 603–6.
18. Chalmers GW, Macleod KJ, Little SA et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57: 226–30.
19. Chaudhuri R, Livinston E, McMahon AD et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168: 1308–11.
20. O'Byrne PM, Bisgaard H, Godard PP et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171: 129–36.
21. Edwards SJ, Gruffydd-Jones K, Ryan DP. Systematic review and meta-analysis of budesonide/formoterol in a single inhaler. Cur Med Res Opin 2007; 23 (8): 1809–20.
22. Ferrari M, Balestreri F, Baratieri S et al. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma. Respiration. 2000; 67: 510–3.
23. Vilsvik J, Ankerst J, Palmqvist M et al. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis. Respir Med 2001; 95: 484–90.
24. Шмелев Е.И. Сочетание бронхиальной астмы и хронической обструктивной болезни легких. Сons Med 2004; 6 (10): 29–33.
25. Mcleish AC, Zvolensky MJ. Asthma and sigarette smoking: a review of the empirical literature. J Asthma 2010; 47: 345–61.
26. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728–73.
27. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004; 126: 117–4.
28. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких. Пересмотр 2007 г. Пер. с англ. М.: Атмосфера, 2008.
29. Чучалин А.Г., Уханова О.П., Шутов Ю.Е. и др. Открытое проспективное наблюдательное исследование эффективности и безопасности свободной комбинации Форадил Аэролайзер и ИГКС у больных БА. Атмосфера, 2009; 4: 26–32.
30. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246–51.
31. van Beerendonk I, Mesters I, Mudde AN et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998; 35: 273–9.
32. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005; 50: 1360–74.
33. Bronsky EA et al. Current medical research and opinion 2004; 20 (2): 131–7.
34. Chew NY, Chan HK. J Aerosol Med 2001; 14 (4): 495–501.
Авторы
Н.М.Ненашева
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.